Učitavanje...

A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly Sensitized Kidney Transplant Candidates

Desensitization protocols comprising plasmapheresis, IVIGs, and rituximab and/or bortezomib have allowed for successful kidney transplantation in some highly HLA-sensitized patients with end-stage renal disease. However, the optimal combination of these therapies and their proper timing remains enti...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transplant Direct
Glavni autori: Ide, Kentaro, Tanaka, Yuka, Sasaki, Yu, Tahara, Hiroyuki, Ohira, Masahiro, Ishiyama, Kohei, Tashiro, Hirotaka, Ohdan, Hideki
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2015
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946466/
https://ncbi.nlm.nih.gov/pubmed/27500219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000526
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!